The inhibition curves suggest a reduced neutralisation efficiency in the CAL-51 breast cancer cell line, which might be attributed to NRP-1-mediated or NRP-1-assisted virus entry [41, 42]. The gene discussed is NRP1; the disease is breast carcinoma.